Literature DB >> 22077646

Large-scale screening of mitochondrial DNA mutations among Iranian patients with prelingual nonsyndromic hearing impairment.

Mostafa Montazer Zohour1, Mohammad Amin Tabatabaiefar, Fatemeh Azadegan Dehkordi, Effat Farrokhi, Mohammad Taghi Akbari, Morteza Hashemzadeh Chaleshtori.   

Abstract

Hereditary hearing impairment (HI) is a genetically heterogeneous disorder caused by mutations either in nuclear DNA (nDNA) or in mitochondrial DNA (mtDNA). The nDNA mutations account for the majority of prelingual nonsyndromic HI (NSHI). The present survey was conducted to screen for known pathogenic mtDNA mutations including A1555G, A3243G, C1494T, and A7445G to provide an accurate estimate of their prevalence in prelingual NSHI for the first time in the Iranian subpopulations. One thousand unrelated probands with NSHI (including both GJB2-negative and GJB2 heterozygote cases) and 1000 healthy matched controls were investigated using the PCR/RFLP method followed by DNA sequencing to confirm the observed mtDNA mutations. Two of the studied mutations, namely A3243G and A7445G, were each found in a single family (a frequency of 0.1% for each). Mutation screening for A3243G followed by DNA sequencing led to the identification of G3316A substitution, with no prior link to HI. Surprisingly, screening for A3243G in the studied population identified 6 cases (0.6%) in probands and 10 (1%) in normal subjects. A1555G, the most common mtDNA mutation associated with deafness in other populations, was not found in the studied samples. To conclude, our findings indicate G3316A as a nonpathogenic variant in the prelingual NSHI subpopulations of Iran and suggest that mtDNA mutations do not play a major role in the etiology of NSHI in Iran.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22077646     DOI: 10.1089/gtmb.2011.0176

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  4 in total

Review 1.  Heterogeneity of Hereditary Hearing Loss in Iran: a Comprehensive Review.

Authors:  Maryam Beheshtian; Mojgan Babanejad; Hela Azaiez; Niloofar Bazazzadegan; Diana Kolbe; Christina Sloan-Heggen; Sanaz Arzhangi; Kevin Booth; Marzieh Mohseni; Kathy Frees; Mohammad Hossein Azizi; Ahmad Daneshi; Mohammad Farhadi; Kimia Kahrizi; Richard Jh Smith; Hossein Najmabadi
Journal:  Arch Iran Med       Date:  2016-10-01       Impact factor: 1.354

2.  Screening for the mitochondrial A1555G mutation among Egyptian patients with non-syndromic, sensorineural hearing loss.

Authors:  Mahmoud R Fassad; Lubna M Desouky; Samir Asal; Ebtesam M Abdalla
Journal:  Int J Mol Epidemiol Genet       Date:  2014-12-15

3.  Audiologic and genetic features of the A3243G mtDNA mutation.

Authors:  Richard J Vivero; Xiaomei Ouyang; Yeunjung Grant Kim; Wendy Liu; Lilin Du; Denise Yan; Xue Zhong Liu
Journal:  Genet Test Mol Biomarkers       Date:  2013-03-11

4.  Frequency of mitochondrial m.1555A > G mutation in Syrian patients with non-syndromic hearing impairment.

Authors:  Hazem Kaheel; Andreas Breß; Mohamed A Hassan; Aftab Ali Shah; Mutaz Amin; Yousuf H Y Bakhit; Marlies Kniper
Journal:  BMC Ear Nose Throat Disord       Date:  2018-05-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.